A plant-based butter sold in 10 states is being recalled due to concerns about yeast, mold, and E. coli, and the U.S. Food and Drug Administration (FDA) has assigned it a risk classification. Multiple outlets report that the FDA’s action follows the recall and provides the product with an official risk designation.
The coverage agrees on the basic cause for the recall—potential contamination involving yeast, mold, and E. coli—and that the product was sold across 10 states in roughly the same timeframe. Several stories specify the FDA risk classification as Class II or describe it as the second-highest risk level, linking the classification to the possibility of illness. One outlet also emphasizes consumer-facing guidance on whether a specific package is affected.
While the factual core is consistent, outlets vary in how they foreground the FDA element versus the recall itself, and in the amount of detail they provide beyond the contamination categories and the geographic scope of the sales.
